Vericel Corp (VCEL)
Every FINRA and SEC series the site collects for Vericel Corp: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances).
4.7M
Short interest
settlement 2026-08-14
11.5
Days to cover
+6.5% vs prior
59.2%
Short share of volume
2026-09-11
520
Fails to deliver
settlement 2026-08-11
-$1.0M
Insider flow, 90 days
0 buys, 5 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 14 August 2026, short interest in VCEL is 4,723,479 shares, up 120,469 shares over the last month. Over the last 48 readings it ranged from 3,390,564 shares (30 August 2024) to 5,629,888 shares (15 August 2025). At the reported average volume of 410K shares a day that is 11.5 days to cover, a crowded short.
Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/vcel" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-14 | 4,723,479 | +6.5% | 409,673 | 11.53 |
| 2026-07-31 | 4,433,745 | -3.7% | 520,404 | 8.52 |
| 2026-07-15 | 4,603,010 | -6.3% | 508,424 | 9.05 |
| 2026-06-30 | 4,913,692 | -7.1% | 922,708 | 5.33 |
| 2026-06-15 | 5,290,119 | +4.2% | 566,581 | 9.34 |
| 2026-05-29 | 5,075,540 | -4.9% | 547,239 | 9.27 |
| 2026-05-15 | 5,335,727 | +7.2% | 706,965 | 7.55 |
| 2026-04-30 | 4,977,488 | -2.0% | 573,785 | 8.67 |
| 2026-04-15 | 5,077,525 | -5.7% | 586,453 | 8.66 |
| 2026-03-31 | 5,384,908 | +6.9% | 889,343 | 6.05 |
| 2026-03-13 | 5,038,948 | +5.1% | 528,377 | 9.54 |
| 2026-02-27 | 4,796,343 | +0.0% | 469,142 | 10.22 |
| 2026-02-13 | 4,796,381 | +4.2% | 406,698 | 11.79 |
| 2026-01-30 | 4,603,413 | +6.0% | 442,773 | 10.40 |
| 2026-01-15 | 4,343,032 | +4.1% | 629,230 | 6.90 |
| 2025-12-31 | 4,172,984 | +10.4% | 566,564 | 7.37 |
| 2025-12-15 | 3,778,372 | -10.0% | 593,294 | 6.37 |
| 2025-11-28 | 4,196,893 | -6.8% | 588,013 | 7.14 |
| 2025-11-14 | 4,501,887 | +1.3% | 781,663 | 5.76 |
| 2025-10-31 | 4,444,085 | -4.7% | 528,615 | 8.41 |
| 2025-10-15 | 4,663,631 | +4.7% | 608,169 | 7.67 |
| 2025-09-30 | 4,454,428 | -6.2% | 970,400 | 4.59 |
| 2025-09-15 | 4,746,206 | -13.8% | 935,951 | 5.07 |
| 2025-08-29 | 5,504,131 | -2.2% | 511,162 | 10.77 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of VCEL volume is 59.2%, down 5.6 points over the last five sessions. Over the last 52 readings it ranged from 24.5% (20 July 2026) to 84.5% (4 September 2026). The latest reading is 3.5 points below the 30-session average of 62.7%, on 189K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 112K | 189K | 59.2% | 107 |
| 2026-09-10 | 121K | 161K | 75.3% | 200 |
| 2026-09-09 | 100K | 138K | 72.5% | 0 |
| 2026-09-08 | 123K | 168K | 73.6% | 14 |
| 2026-09-04 | 85K | 101K | 84.5% | 6,878 |
| 2026-09-03 | 62K | 96K | 64.8% | 60 |
| 2026-09-02 | 68K | 126K | 54.2% | 221 |
| 2026-09-01 | 152K | 222K | 68.2% | 0 |
| 2026-08-31 | 148K | 204K | 72.3% | 0 |
| 2026-08-28 | 87K | 173K | 50.4% | 0 |
| 2026-08-27 | 105K | 176K | 59.3% | 0 |
| 2026-08-26 | 86K | 119K | 72.0% | 0 |
| 2026-08-25 | 144K | 197K | 72.8% | 0 |
| 2026-08-24 | 94K | 236K | 39.7% | 0 |
| 2026-08-21 | 134K | 225K | 59.5% | 0 |
| 2026-08-20 | 106K | 165K | 64.6% | 0 |
| 2026-08-19 | 185K | 241K | 76.7% | 0 |
| 2026-08-18 | 122K | 229K | 53.0% | 511 |
| 2026-08-17 | 58K | 92K | 62.8% | 0 |
| 2026-08-14 | 71K | 106K | 66.9% | 6,101 |
| 2026-08-13 | 70K | 220K | 31.6% | 136 |
| 2026-08-12 | 65K | 96K | 67.3% | 0 |
| 2026-08-11 | 133K | 173K | 76.6% | 0 |
| 2026-08-10 | 95K | 152K | 62.5% | 0 |
| 2026-08-07 | 75K | 162K | 46.3% | 0 |
| 2026-08-06 | 75K | 133K | 56.5% | 0 |
| 2026-08-05 | 106K | 179K | 59.1% | 0 |
| 2026-08-04 | 88K | 154K | 57.1% | 0 |
| 2026-08-03 | 99K | 169K | 58.2% | 0 |
| 2026-07-31 | 110K | 175K | 62.7% | 0 |
Fails to deliver
SEC, by settlement date. JSONAs of 11 August 2026, the fails-to-deliver balance in VCEL is 520 shares, up 515 shares over the last settlement date. Over the last 52 readings it ranged from 1 share (23 March 2026) to 61,101 shares (28 November 2025). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-11 | 520 | $43.95 | $23K |
| 2026-08-06 | 5 | $45.36 | $227 |
| 2026-07-24 | 140 | $45.05 | $6K |
| 2026-07-23 | 100 | $44.56 | $4K |
| 2026-07-22 | 100 | $46.14 | $5K |
| 2026-07-16 | 92 | $46.72 | $4K |
| 2026-07-09 | 1,576 | $47.02 | $74K |
| 2026-07-08 | 2 | $46.95 | $94 |
| 2026-07-06 | 3,089 | $46.98 | $145K |
| 2026-06-30 | 11,202 | $45.07 | $505K |
| 2026-06-29 | 146 | $46.23 | $7K |
| 2026-06-26 | 9 | $42.90 | $386 |
| 2026-06-24 | 1,204 | $40.39 | $49K |
| 2026-06-05 | 137 | $35.69 | $5K |
| 2026-06-02 | 888 | $32.82 | $29K |
| 2026-04-30 | 14 | $33.43 | $468 |
| 2026-04-27 | 848 | $35.64 | $30K |
| 2026-04-24 | 238 | $34.40 | $8K |
| 2026-04-06 | 44 | $34.14 | $2K |
| 2026-03-31 | 7,126 | $30.55 | $218K |
| 2026-03-23 | 1 | $31.41 | $31 |
| 2026-03-20 | 202 | $32.74 | $7K |
| 2026-03-17 | 418 | $32.29 | $13K |
| 2026-03-06 | 377 | $34.00 | $13K |
| 2026-02-20 | 337 | $38.17 | $13K |
| 2026-02-19 | 187 | $37.41 | $7K |
| 2026-02-17 | 2 | $35.96 | $72 |
| 2026-02-09 | 2,768 | $36.19 | $100K |
| 2026-02-06 | 221 | $35.38 | $8K |
| 2026-01-30 | 26 | $36.50 | $949 |
Insider trades
SEC Form 4, newest first, 50 of 78 shown. JSONInsiders at VCEL reported 5 open-market sells worth $1.0M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: MCLAUGHLIN KEVIN F on 2026-08-12.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | MCLAUGHLIN KEVIN F | n/a | Sell | 7K | $44.53 | $312K | 18K |
| 2026-08-12 | MCLAUGHLIN KEVIN F | n/a | Option exercise | 7K | $13.05 | $91K | 25K |
| 2026-08-03 | Halpin Michael | Chief Operating Officer | Sell | 10K | $46.84 | $468K | 16K |
| 2026-08-03 | Halpin Michael | Chief Operating Officer | Option exercise | 10K | $16.66 | $167K | 26K |
| 2026-07-30 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 500 | $48.90 | $24K | 1K |
| 2026-07-30 | SIEGAL JONATHAN | Principal Accounting Officer | Option exercise | 500 | $29.82 | $15K | 2K |
| 2026-07-30 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 3K | $48.90 | $122K | 1K |
| 2026-07-30 | SIEGAL JONATHAN | Principal Accounting Officer | Option exercise | 3K | $29.82 | $75K | 4K |
| 2026-07-30 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 2K | $48.90 | $73K | 1K |
| 2026-07-30 | SIEGAL JONATHAN | Principal Accounting Officer | Option exercise | 2K | $34.90 | $52K | 3K |
| 2026-06-02 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 4K | $35.00 | $153K | 76K |
| 2026-06-02 | Hopper Jonathan Mark | Chief Medical Officer | Option exercise | 4K | $16.66 | $73K | 80K |
| 2026-05-13 | MCLAUGHLIN KEVIN F | n/a | Sell | 4K | $32.83 | $115K | 18K |
| 2026-05-13 | MCLAUGHLIN KEVIN F | n/a | Option exercise | 4K | $2.63 | $9K | 22K |
| 2026-05-11 | Wotton Paul K | n/a | Sell | 8K | $32.64 | $245K | 19K |
| 2026-05-11 | Wotton Paul K | n/a | Sell | 3K | $33.05 | $83K | 26K |
| 2026-05-07 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1K | $40.50 | $58K | 1K |
| 2026-05-07 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 5K | $40.50 | $203K | 21K |
| 2026-05-06 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 3K | $38.00 | $130K | 3K |
| 2026-04-02 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 3K | $35.00 | $122K | 76K |
| 2026-04-02 | Hopper Jonathan Mark | Chief Medical Officer | Option exercise | 3K | $10.95 | $38K | 79K |
| 2026-03-25 | Rubino Alan L | n/a | Option exercise | 15K | $2.76 | $41K | 61K |
| 2026-03-23 | Hagen Heidi | n/a | Sell | 15K | $32.41 | $486K | 32K |
| 2026-03-23 | Hagen Heidi | n/a | Option exercise | 15K | $2.76 | $41K | 47K |
| 2026-03-02 | Halpin Michael | Chief Operating Officer | Sell | 10K | $35.30 | $364K | 16K |
| 2026-03-02 | Flynn Sean C. | Chief Legal Officer | Sell | 15K | $35.36 | $530K | 1K |
| 2026-03-02 | Flynn Sean C. | Chief Legal Officer | Option exercise | 15K | $16.25 | $244K | 16K |
| 2026-03-02 | Flynn Sean C. | Chief Legal Officer | Sell | 6K | $34.75 | $223K | 1K |
| 2026-02-24 | SIEGAL JONATHAN | Principal Accounting Officer | Tax withholding | 738 | $38.25 | $28K | 6K |
| 2026-02-24 | SIEGAL JONATHAN | Principal Accounting Officer | Option exercise | 2K | $0.00 | $0 | 7K |
| 2026-02-24 | SIEGAL JONATHAN | Principal Accounting Officer | Tax withholding | 627 | $38.09 | $24K | 5K |
| 2026-02-24 | SIEGAL JONATHAN | Principal Accounting Officer | Option exercise | 2K | $0.00 | $0 | 5K |
| 2026-02-24 | Mara Joseph Anthony Jr | Chief Financial Officer | Tax withholding | 1K | $38.09 | $52K | 23K |
| 2026-02-24 | Mara Joseph Anthony Jr | Chief Financial Officer | Option exercise | 5K | $0.00 | $0 | 24K |
| 2026-02-24 | Halpin Michael | Chief Operating Officer | Tax withholding | 2K | $38.09 | $95K | 24K |
| 2026-02-24 | Halpin Michael | Chief Operating Officer | Option exercise | 5K | $0.00 | $0 | 26K |
| 2026-02-24 | Flynn Sean C. | Chief Legal Officer | Tax withholding | 1K | $38.25 | $51K | 8K |
| 2026-02-24 | Flynn Sean C. | Chief Legal Officer | Option exercise | 3K | $0.00 | $0 | 9K |
| 2026-02-24 | Flynn Sean C. | Chief Legal Officer | Tax withholding | 2K | $38.09 | $59K | 6K |
| 2026-02-24 | Flynn Sean C. | Chief Legal Officer | Option exercise | 4K | $0.00 | $0 | 8K |
| 2026-02-18 | SIEGAL JONATHAN | Principal Accounting Officer | Tax withholding | 188 | $37.41 | $7K | 4K |
| 2026-02-18 | SIEGAL JONATHAN | Principal Accounting Officer | Option exercise | 420 | $0.00 | $0 | 4K |
| 2026-02-18 | SIEGAL JONATHAN | Principal Accounting Officer | Tax withholding | 1K | $36.82 | $41K | 4K |
| 2026-02-18 | SIEGAL JONATHAN | Principal Accounting Officer | Option exercise | 3K | $0.00 | $0 | 5K |
| 2026-02-18 | Mara Joseph Anthony Jr | Chief Financial Officer | Tax withholding | 809 | $37.41 | $30K | 19K |
| 2026-02-18 | Mara Joseph Anthony Jr | Chief Financial Officer | Option exercise | 3K | $0.00 | $0 | 20K |
| 2026-02-18 | Mara Joseph Anthony Jr | Chief Financial Officer | Tax withholding | 2K | $36.82 | $55K | 17K |
| 2026-02-18 | Mara Joseph Anthony Jr | Chief Financial Officer | Option exercise | 5K | $0.00 | $0 | 19K |
| 2026-02-18 | Halpin Michael | Chief Operating Officer | Tax withholding | 2K | $37.41 | $68K | 21K |
| 2026-02-18 | Halpin Michael | Chief Operating Officer | Option exercise | 4K | $0.00 | $0 | 23K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON3 Form 144 notices on file for VCEL worth $989K at the prices reported; 3 in the last 90 days worth $989K. Latest: MCLAUGHLIN KEVIN F filed on 2026-08-12 to sell 7,000 shares ($309K) from 2026-08-12.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-12 | MCLAUGHLIN KEVIN FDirector | 7K | $309K | 0.014% | 2026-08-12 | Fidelity Brokerage Services LLC |
| 2026-08-03 | Halpin MichaelOfficer | 10K | $460K | 0.020% | 2026-08-03 | Fidelity Brokerage Services LLC |
| 2026-07-30 | SIEGAL JONATHANOfficer | 5K | $220K | 0.009% | 2026-07-30 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON6 holders above 5% have filed on VCEL, all on Schedule 13G (passive). The largest reported stake is Soleus Capital Master Fund, L.P. at 2.8% of the class (1,458,882 shares), filed 2026-08-13 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-13 | 13G/Ano. 1 | Soleus Capital Master Fund, L.P.non-US institution | 1.5M | 2.8% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 1 | Soleus Capital, LLCother entity | 1.5M | 2.8% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 1 | Soleus Capital Group, LLCother entity | 1.5M | 2.8% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 1 | Soleus Capital Management, L.P.partnership | 1.5M | 2.8% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 1 | Soleus GP, LLCother entity | 1.5M | 2.8% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 1 | Guy Levyindividual | 1.5M | 2.8% | 2026-06-30 |
13F holders
Tracked managers holding VCEL at their latest 13F. JSON6 of the 30 tracked managers held VCEL at their latest 13F, $88.1M in total at quarter-end prices. Two Sigma Investments is the largest at $25.8M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 581K | $25.8M | 0.02% | +96K |
| D. E. Shaw & Co. | 2026-06-30 | 452K | $20.1M | 0.01% | +157K |
| Point72 Asset Management | 2026-06-30 | 443K | $19.7M | 0.02% | +279K |
| AQR Capital Management | 2026-06-30 | 283K | $12.6M | 0.00% | +235K |
| Fisher Asset Management | 2026-06-30 | 185K | $8.2M | 0.00% | 0 |
| Citadel Advisors | 2026-06-30 | 35K | $1.6M | 0.00% | -78K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) Vericel Corp reported revenue of $77.5M, up 22.5% from the same quarter a year earlier, and net income of $2.2M (0.04 diluted EPS). In FY 2025 it generated $51.9M of operating cash flow.
- Cash
- $125.4M
- Equity
- $370.0M
- Total assets
- $502.9M
- Shares outstanding
- 51,206,614
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $77.5M | $2.2M | 2.8% | 0.04 |
| Q1 2026 | 2026-03-31 | $68.4M | -$6.3M | -9.2% | -0.12 |
| Q4 2025derived | 2025-12-31 | $92.9M | $23.2M | 25.0% | n/a |
| Q3 2025 | 2025-09-30 | $67.5M | $5.1M | 7.5% | 0.10 |
| Q2 2025 | 2025-06-30 | $63.2M | -$553K | -0.9% | -0.01 |
| Q1 2025 | 2025-03-31 | $52.6M | -$11.2M | -21.4% | -0.23 |
| Q4 2024derived | 2024-12-31 | $75.4M | $19.8M | 26.3% | n/a |
| Q3 2024 | 2024-09-30 | $57.9M | -$901K | -1.6% | -0.02 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $276.3M | $16.5M | $51.9M | $27.2M | n/a | n/a |
| FY 2024 | 2024-12-31 | $237.2M | $10.4M | $58.2M | $64.0M | n/a | n/a |
| FY 2023 | 2023-12-31 | $197.5M | -$3.2M | $35.3M | $20.0M | n/a | n/a |
| FY 2022 | 2022-12-31 | $163.7M | -$16.7M | $17.7M | $7.6M | n/a | n/a |
| FY 2021 | 2021-12-31 | $153.1M | -$7.5M | $29.0M | $7.9M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-24 from the cover page.
What this page is
Vericel Corp in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows Vericel Corp (VCEL), SEC CIK 887359, listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-11.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-08-12.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-13.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-08-12.JSON and CSV
- Company record
- EDGAR filing index for CIK 887359Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 09:50 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as biological products, (no diagnostic substances)
- KYMRKymera Therapeutics, Inc.
- ADPTAdaptive Biotechnologies Corp
- TWSTTwist Bioscience Corp
- HALOHALOZYME THERAPEUTICS, INC.
- KRYSKrystal Biotech, Inc.
- NBIXNEUROCRINE BIOSCIENCES INC
- RVMDRevolution Medicines, Inc.
- AMGNAMGEN INC
- MAZEMaze Therapeutics, Inc.
- GILDGILEAD SCIENCES, INC.
- RXRXRECURSION PHARMACEUTICALS, INC.
- APGEApogee Therapeutics, Inc.
- FENCFENNEC PHARMACEUTICALS INC.
- PCVXVaxcyte, Inc.
- BIIBBIOGEN INC.
- VORVor Biopharma Inc.
- EXELEXELIXIS, INC.
- SRRKScholar Rock Holding Corp
- ADMAADMA BIOLOGICS, INC.
- TECHBIO-TECHNE Corp
- ARTVArtiva Biotherapeutics, Inc.
- BCRXBIOCRYST PHARMACEUTICALS INC
- VIRVir Biotechnology, Inc.
- IOVAIOVANCE BIOTHERAPEUTICS, INC.
Datasets
Frequently Asked Questions
How much of VCEL is sold short?
What is VCEL's daily short volume?
Does VCEL have fails to deliver?
Are VCEL insiders buying or selling?
Have VCEL insiders filed to sell?
Who owns more than 5% of VCEL?
What did VCEL report last quarter?
Which funds hold VCEL?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.